270. 慢性再発性多発性骨髄炎 Disease details / Clinical trials / Drug dev / DR info

臨床試験数 : 1 / 薬物数 : 11 - (DrugBank : 9) / 標的遺伝子数 : 6 - 標的パスウェイ数 : 71

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Adalimumab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Certolizumab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Etanercept
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Golimumab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Infliximab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Leflunomide
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Methotrexate
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Nsaid
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Pamidronate
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Sulfasalazine
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Zoledronic acid
   Seattle Children's Hospital
      2018   -   NCT04725422   United States